ES2053834T3 - Un metodo para la preparacion de una sustancia terapeutica. - Google Patents

Un metodo para la preparacion de una sustancia terapeutica.

Info

Publication number
ES2053834T3
ES2053834T3 ES89103699T ES89103699T ES2053834T3 ES 2053834 T3 ES2053834 T3 ES 2053834T3 ES 89103699 T ES89103699 T ES 89103699T ES 89103699 T ES89103699 T ES 89103699T ES 2053834 T3 ES2053834 T3 ES 2053834T3
Authority
ES
Spain
Prior art keywords
preparation
therapeutic substance
dipeptide
piroglutamil
cataracts
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES89103699T
Other languages
English (en)
Inventor
Giuseppe Dr Benanti
Victor Prof Rizza
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
S I F I Industria Farmaceutica Italiana SpA Soc
Original Assignee
S I F I Industria Farmaceutica Italiana SpA Soc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by S I F I Industria Farmaceutica Italiana SpA Soc filed Critical S I F I Industria Farmaceutica Italiana SpA Soc
Application granted granted Critical
Publication of ES2053834T3 publication Critical patent/ES2053834T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06139—Dipeptides with the first amino acid being heterocyclic
    • C07K5/06173—Dipeptides with the first amino acid being heterocyclic and Glp-amino acid; Derivatives thereof

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

SE PRESENTA EL L - PIROGLUTAMIL - L - CISTEINA DIPEPTIDA DE FORMULA I, ESTE DIPEPTIDO HA EXHIBIDO UNA ALTA ACTIVIDAD EN LA PREVENCION Y TERAPIA DE CATARATAS TANTO EN HOMBRE COMO EN ANIMALES.
ES89103699T 1988-03-15 1989-03-03 Un metodo para la preparacion de una sustancia terapeutica. Expired - Lifetime ES2053834T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT8819783A IT1216096B (it) 1988-03-15 1988-03-15 L_piroglutamil_l_cisteina, dipeptide ad elevata attivita'anticatarattogena e composizioni farmaceutiche che lo contengono.

Publications (1)

Publication Number Publication Date
ES2053834T3 true ES2053834T3 (es) 1994-08-01

Family

ID=11161182

Family Applications (1)

Application Number Title Priority Date Filing Date
ES89103699T Expired - Lifetime ES2053834T3 (es) 1988-03-15 1989-03-03 Un metodo para la preparacion de una sustancia terapeutica.

Country Status (5)

Country Link
EP (1) EP0332946B1 (es)
AT (1) ATE89288T1 (es)
DE (1) DE68906437T2 (es)
ES (1) ES2053834T3 (es)
IT (1) IT1216096B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1249650B (it) * 1991-05-29 1995-03-09 Poli Ind Chimica Spa N-(5-tioxo-l-prolil)-l-cisteina e suoi derivati, loro preparazione ed impiego terapeutico
IT1256178B (it) * 1992-11-30 1995-11-29 Lorenzo Ferrari Composti ad attivita' terapeutica utili per il trattamento di malattieconnesse ad una carenza di glutatione, procedimento per la loro preparazione e composizioni farmaceutiche che li contengono.
US5624955A (en) * 1995-05-03 1997-04-29 Regents Of The University Of Minnesota Compounds that enhance the concentration of glutathione in tissues

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8500847A (nl) * 1984-03-29 1985-10-16 Sandoz Ag Gesubstitueerde alfa-aminozuren, hun bereiding en farmaceutische preparaten die ze bevatten.

Also Published As

Publication number Publication date
ATE89288T1 (de) 1993-05-15
IT8819783A0 (it) 1988-03-15
EP0332946B1 (en) 1993-05-12
EP0332946A1 (en) 1989-09-20
IT1216096B (it) 1990-02-22
DE68906437T2 (de) 1993-09-09
DE68906437D1 (de) 1993-06-17

Similar Documents

Publication Publication Date Title
ATE107858T1 (de) Pharmazeutische zusammensetzung zum abnehmen.
ES2123064T3 (es) Uso de melatonina en pequeñas dosis orales como somnifero.
ATE74519T1 (de) Waessrige loesung von fettloeslichen wirkstoffen.
IT8719405A0 (it) Protesi interna per la sostituzione di una parte del corpo umano particolarmente nelle operazioni vascolari.
DE3382641D1 (de) Arzneimittel fuer die therapeutische behandlung von alopezie.
DE69327432D1 (de) Heilmittel für wunden und hämorrhoiden
EP0276317A4 (en) GAMMA-L-GLUTAMYL-L-CYSTEINE ETHYL ESTER AND MEDICINE CONTAINING THE SAME AS AN ACTIVE INGREDIENT.
RU93032613A (ru) Фармацевтический препарат для лечения пациентов с пролонгированным временем коагуляции, способ лечения пациентов, применение epi ингибитора для получения фармацевтического препарата
DE69007592D1 (de) Transdermal absorbierbare Dopaminderivate enthaltende Arzneizubereitungen.
ES2059375T3 (es) Utilizacion del tetrahidrocortisol en la terapia del glaucoma.
DE69116380D1 (de) Pharmazeutische zubereitung zur behandlung verlängerter gerinnungszeit
NO870772L (no) Vevplasminogenaktivator for normale humane tykktarmceller.
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
DE69130586D1 (de) Behandlung von Pankreaskrankheit mit 15-keto-Prostaglandin E-Derivaten
BG50159A3 (bg) Метод за получаване на производни на пиранобензоксадиазол
ATE84716T1 (de) 4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
DE68912020D1 (de) N-2,3-Butadienyl-tri-aminoalkanderivate.
ES2053834T3 (es) Un metodo para la preparacion de una sustancia terapeutica.
AU3401093A (en) Therapeutic agent for threatened abortion
DE69032000D1 (de) Behandlung kardialer Dysfunktion mit 15-Ketoprostaglandinderivaten
KR100488038B1 (ko) 기관 보호 활성을 지닌 신규한 신체 보호 화합물 펩티드염, 이의 제조 방법 및 치료에서의 이의 용도
ES2094757T3 (es) Un factor megacariocitopoyetico.
KR900009029A (ko) 가축병 치료용 약물을 투여하는 장치
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
MX9203735A (es) Una forma de dosis mejorada para suministrar una droga o un agente terapeutico a un ambiente de uso.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 332946

Country of ref document: ES